(Q37237496)

English

Invariant natural killer T cell-natural killer cell interactions dictate transplantation outcome after alpha-galactosylceramide administration

scientific article published on 15 April 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Invariant natural killer T cell-natural killer cell interactions dictate transplantation outcome after alpha-galactosylceramide administration (English)

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

13

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

object named as

Kate A Markey

4

0 references

Geoffrey R Hill

object named as

Geoffrey R Hill

17

0 references

Andrew D. Clouston

object named as

Andrew D Clouston

11

0 references

object named as

Mark J Smyth

15

0 references

Steven A Porcelli

16

object named as

Steven A Porcelli

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Kelli P MacDonald

3

object named as

Kelli P A Macdonald

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

author name string

Rachel D Kuns

1

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Edward S Morris

2

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Helen M Morris

5

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Neil C Raffelt

6

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Tatjana Banovic

7

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Alistair L J Don

8

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Vanessa Rowe

9

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Angela C Burman

10

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Camile Farah

12

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Petr A Illarionov

14

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

language of work or name

0 references

publication date

15 April 2009

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

113

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

23

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

5999-6010

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Type I NKT cells protect (and type II NKT cells suppress) the host's innate antitumor immune response to a B-cell lymphoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2700331

6 September 2017

NKT cells in immunoregulation of tumor immunity: a new immunoregulatory axis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2700331

6 September 2017

Missing KIR ligands are associated with less relapse and increased graft-versus-host disease (GVHD) following unrelated donor allogeneic HCT.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2700331

6 September 2017

Stem cell mobilization with G-CSF analogs: a rational approach to separate GVHD and GVL?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2700331

6 September 2017

A nonclassical non-Valpha14Jalpha18 CD1d-restricted (type II) NKT cell is sufficient for down-regulation of tumor immunosurveillance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2700331

6 September 2017

Differential antitumor immunity mediated by NKT cell subsets in vivo

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2700331

6 September 2017

NKT cell-dependent leukemia eradication following stem cell mobilization with potent G-CSF analogs.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2700331

6 September 2017

KIR reconstitution is altered by T cells in the graft and correlates with clinical outcomes after unrelated donor transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2700331

6 September 2017

Modulation of CD1d-restricted NKT cell responses by using N-acyl variants of alpha-galactosylceramides

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2700331

6 September 2017

The linkage of innate to adaptive immunity via maturing dendritic cells in vivo requires CD40 ligation in addition to antigen presentation and CD80/86 costimulation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2700331

6 September 2017

Natural killer T cells as targets for immunotherapy of autoimmune diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2700331

6 September 2017

A critical role for natural killer T cells in immunosurveillance of methylcholanthrene-induced sarcomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2700331

6 September 2017

Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2700331

6 September 2017

Cross-regulation between type I and type II NKT cells in regulating tumor immunity: a new immunoregulatory axis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2700331

14 September 2017

Inhibition of antitumor immunity by invariant natural killer T cells in a T-cell lymphoma model in vivo

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2700331

14 September 2017

Donor bone marrow type II (non-Valpha14Jalpha18 CD1d-restricted) NKT cells suppress graft-versus-host disease by producing IFN-gamma and IL-4.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2700331

3 September 2018

Host NKT cells can prevent graft-versus-host disease and permit graft antitumor activity after bone marrow transplantation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2700331

3 September 2018

Host-residual invariant NK T cells attenuate graft-versus-host immunity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2700331

3 September 2018

NKT cells: what's in a name?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2700331

3 September 2018

Donor treatment with pegylated G-CSF augments the generation of IL-10-producing regulatory T cells and promotes transplantation tolerance.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2700331

3 September 2018

A common pathway for chemotherapy-induced apoptosis in human squamous cell carcinoma lines distinct from that of receptor-mediated cell death.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2700331

3 September 2018

Peptide antigen priming of naive, but not memory, CD8 T cells requires a third signal that can be provided by IL-12.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2700331

3 September 2018

IFN differentially controls the development of idiopathic pneumonia syndrome and GVHD of the gastrointestinal tract

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2700331

4 December 2018

CD4 and CD8 expression by dendritic cell subtypes in mouse thymus and spleen

1 reference

https://pubmed.ncbi.nlm.nih.gov/19369232

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Total body irradiation and acute graft-versus-host disease: the role of gastrointestinal damage and inflammatory cytokines

1 reference

https://pubmed.ncbi.nlm.nih.gov/19369232

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin-12 preserves the graft-versus-leukemia effect of allogeneic CD8 T cells while inhibiting CD4-dependent graft-versus-host disease in mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/19369232

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin-12 inhibits graft-versus-host disease through an Fas-mediated mechanism associated with alterations in donor T-cell activation and expansion

1 reference

https://pubmed.ncbi.nlm.nih.gov/19369232

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Stimulation of Host NKT Cells by Synthetic Glycolipid Regulates Acute Graft-versus-Host Disease by Inducing Th2 Polarization of Donor T Cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/19369232

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A crucial role for antigen-presenting cells and alloantigen expression in graft-versus-leukemia responses

1 reference

https://pubmed.ncbi.nlm.nih.gov/19369232

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Donor APCs are required for maximal GVHD but not for GVL

1 reference

https://pubmed.ncbi.nlm.nih.gov/19369232

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1182/BLOOD-2008-10-183335

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37237496&oldid=2145883015"